News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Conference News TCT 2015 Trial Results Often Struggle to Keep Pace With Evolving Technology Nicole Lou October 13, 2015